Tradeshows Simply fairs
Menu

World ADC Berlin 2018

  • From to
  • Berlin (Germany)

World ADC Berlin

World ADC Berlin: the trade show

World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data. Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40+ others will divulge unpublished, never seen before ADC drug research.Over 3 days, 60+ sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC program. Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.Join 300+ industry experts at the definitive ADC learning forum and:

  • Understand how Seattle Genetics developed high-DAR ADCs with superior in vivo performance using an innovative linker design
  • Enhance chances of successful regulatory approval by hearing views from the FDA
  • Effectively scale up from clinical to commercial manufacturing with four clinical case studies on building and maintaining a robust ADC manufacturing CMO network from Pfizer
  • Successfully develop warheads with different mechanisms of action with lesson learned from PBDs at Spirogen
  • Overcome serum stability issues associated with thiol linked antibody drug conjugates using N-alkyl maleimides from MedImmune
  • Identify novel ADC targets which have improved internalisation at a higher frequency with insight from Genmab
  • Improve understanding of IgG limitations and discover validated alternative antibody formats with Roche
  • Improve pharmacokinetic understanding using cutting edge analytical and bioanalytical characterisation approaches from Pierre-Fabre
  • Maximise the ADC drug therapeutic window by learning how to effectively manage off-target toxicities with Bayer
  • Digest the latest clinical outcomes by reviewing results for the IMMU-132 Phase II for solid cancers which have had multiple prior therapies from Immunomedics
Time: 9:00 am - 5:00 pmPrice:Earlybird until 18 Dec: Gold - conference & 2 workshops: EUR 3197Earlybird until 18 Dec: Silver: Conference + 1 workshop: EUR 2798Earlybird until 18 Dec: Bronze: Conference only: EUR 2299Standard: Gold: Conference + 2 workshops: EUR 3497Standard: Silver: Conference + 1 workshop: EUR 2998Standard: Bronze: Conference only: EUR 2499Workshop only: EUR 599Speakers: Alain Beck, Anette Sommer, Antony Godwin, Arnaud Delobel, Bart De Goeij, Ben-fillippo Krippendorff, Brian Clark, Cecile Chalouni, Chris Lloyd, Christopher Leamon, Cynthia Wooge, Ph.D, Daryl Drummond, David Goldenberg, David Miao, David Thurston, Eric Lacoste, Fabian Brandl, Feng Tian, Francisco Ylera, Giulio Casi, Ian Evetts, Jackson Burton, James Munday, John Gebler, John Lambert, Justin Mason-Home, Maarten Postema, Maria Elena Guadagno, Martin Dyer, Matthew Meyer, Nathan Tumey, Nazzaerno Dimasi, Palani Palaniappan, Pernille Hemmingsen, Peter Lloyd, Petter Veiby, Phil Brandish, Philip Howard, Puja Sapra, Rakesh Dixit, Robert Lutz, Robert Lyon

February 2016 Edition:

Now in its 6th year, World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data. Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40+ others will divulge unpublished, never seen before ADC drug research.Over 3 days, 60+ sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC program. Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.Join 300+ industry experts at the definitive ADC learning forum and:Understand how Seattle Genetics developed high-DAR ADCs with superior in vivo performance using an innovative linker designEnhance chances of successful regulatory approval by hearing views from the FDAEffectively scale up from clinical to commercial manufacturing with four clinical case studies on building and maintaining a robust ADC manufacturing CMO network from PfizerSuccessfully develop warheads with different mechanisms of action with lesson learned from PBDs at SpirogenOvercome serum stability issues associated with thiol linked antibody drug conjugates using N-alkyl maleimides from MedImmuneIdentify novel ADC targets which have improved internalisation at a higher frequency with insight from GenmabImprove understanding of IgG limitations and discover validated alternative antibody formats with RocheImprove pharmacokinetic understanding using cutting edge analytical and bioanalytical characterisation approaches from Pierre-FabreMaximise the ADC drug therapeutic window by learning how to effectively manage off-target toxicities with BayerDigest the latest clinical outcomes by reviewing results for the IMMU-132 Phase II for solid cancers which have had multiple prior therapies from Immunomedics

February 2016 Edition:

Now in its 6th year, World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data. Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40+ others will divulge unpublished, never seen before ADC drug research.Over 3 days, 60+ sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC program. Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.Join 300+ industry experts at the definitive ADC learning forum and:Understand how Seattle Genetics developed high-DAR ADCs with superior in vivo performance using an innovative linker designEnhance chances of successful regulatory approval by hearing views from the FDAEffectively scale up from clinical to commercial manufacturing with four clinical case studies on building and maintaining a robust ADC manufacturing CMO network from PfizerSuccessfully develop warheads with different mechanisms of action with lesson learned from PBDs at SpirogenOvercome serum stability issues associated with thiol linked antibody drug conjugates using N-alkyl maleimides from MedImmuneIdentify novel ADC targets which have improved internalisation at a higher frequency with insight from GenmabImprove understanding of IgG limitations and discover validated alternative antibody formats with RocheImprove pharmacokinetic understanding using cutting edge analytical and bioanalytical characterisation approaches from Pierre-FabreMaximise the ADC drug therapeutic window by learning how to effectively manage off-target toxicities with BayerDigest the latest clinical outcomes by reviewing results for the IMMU-132 Phase II for solid cancers which have had multiple prior therapies from Immunomedics

Event profile World ADC Berlin

  • Industries:
  • Frequency: Biennial
  • Scope: National

World ADC Berlin 2016

Now in its 6th year, World ADC Berlin is the industry’s definitive conference for sharing new antibody drug conjugate insights and data. Thought leaders from Pfizer, MedImmune, Genentech, Merck and 40+ others will divulge unpublished, never seen before ADC drug research.Over 3 days, 60+ sessions will cover every aspect of ADC drug development from discovery, preclinical, clinical and marketisation giving you an unparalleled opportunity to gain insights and advance your ADC program. Make sure you keep pace with the latest advancements and develop the next generation of therapeutically successful ADCs.Join 300+ industry experts at the definitive ADC learning forum and:Understand how Seattle Genetics developed high-DAR ADCs with superior in vivo performance using an innovative linker designEnhance chances of successful regulatory approval by hearing views from the FDAEffectively scale up from clinical to commercial manufacturing with four clinical case studies on building and maintaining a robust ADC manufacturing CMO network from PfizerSuccessfully develop warheads with different mechanisms of action with lesson learned from PBDs at SpirogenOvercome serum stability issues associated with thiol linked antibody drug conjugates using N-alkyl maleimides from MedImmuneIdentify novel ADC targets which have improved internalisation at a higher frequency with insight from GenmabImprove understanding of IgG limitations and discover validated alternative antibody formats with RocheImprove pharmacokinetic understanding using cutting edge analytical and bioanalytical characterisation approaches from Pierre-FabreMaximise the ADC drug therapeutic window by learning how to effectively manage off-target toxicities with BayerDigest the latest clinical outcomes by reviewing results for the IMMU-132 Phase II for solid cancers which have had multiple prior therapies from Immunomedics

World ADC Berlin editions

Edition Date Localizatiob
World ADC Berlin 2018 From to Berlin, Germany
World ADC Berlin 2018 From to Berlin, Germany
World ADC Berlin 2017 From to Berlin, Germany
World ADC Berlin 2016 From to Berlin, Germany

World ADC Berlin organizer

  • Hanson Wade
  • London (United Kingdom)

Choose your profile and discover all you can do in neventum!

I'm an Event Organizer

I exhibit at trade shows

I'm a Supplier, stands...